Chinanews.com client Beijing, May 31 (Peng Jingru) "The divorce cooling-off period of 30 days" has not completely passed, and A shares have reproduced sky-high divorce.

　　Vaccine giant Kangtai Biological announced recently that due to the dissolution of marriage and the division of property, Du Weimin, the company's controlling shareholder and actual controller, plans to transfer 161 million shares of the company to Ms. YUAN LIPING (Yuan Liping).

Kangtai Bio's stock price chart.

23.5 billion breakup fee sets A-share record

　　What is the concept of 161 million shares?

　　According to Kangtai Biotechnology's latest closing price of 146 yuan / share, the market value of Du Weimin's split shares reached 23.5 billion yuan, which is 235 "small targets", setting a record high in the history of A shares. The previous highest record was that Zhou Yahui, the chairman of Kunlun Wanwei, divorced in September 2016, and the breakup fee exceeded 7.5 billion yuan.

　　According to the announcement of Kangtai Biology, after this share split, Du Weimin directly held 183,394,125 shares of Kangtai Biotechnology, accounting for 27.27% of the company's total shares, of which 23,484,740 shares were pledged, accounting for 12.81% of the total number of company shares he held; Ms. YUAN LIPING directly holds 161,331,675 shares of Kangtai Biotechnology, accounting for 23.99% of the company's total shares.

Announcement issued by Kangtai Bio.

　　Behind the sky-high breakup fee is Kangtai Bio's stock price skyrocketing. Since this year, Kangtai Bio's stock price has risen by nearly 66%, with a total market value of 98.184 billion yuan. Compared with the stock price as low as about 27 yuan during the Changchun longevity vaccine vaccine crisis, Kangtai Biotechnology's stock price has now increased more than five times.

　　The skyrocketing of Kangtai Bio's stock price is related to the announcement in February 2020 of cooperation with Ai Di Weixin (Suzhou) Biopharmaceutical Co., Ltd. to develop a new coronavirus (2019-nCoV) DNA (hereinafter referred to as the new crown DNA vaccine) vaccine. Before announcing its participation in the development of the new crown DNA vaccine, Kangtai Biotechnology's stock price was around 100 yuan. Since the outbreak of the New Crown epidemic, Kangtai Biotech's stock price has also increased to a certain extent, but the increase is much smaller than after the announcement of the development of a new crown DNA vaccine.

　　According to the official website information, Kangtai Bio is an enterprise integrating R & D, production and sales of biological products. It was established in September 1992 with a registered capital of 369 million yuan. It is headquartered in Shenzhen and was on the Shenzhen Stock Exchange on February 7, 2017. GEM is listed.

　　Kangtai Biology started with a vaccine. The company's main products include recombinant hepatitis B vaccine (Saccharomyces cerevisiae), Haemophilus influenzae type b conjugate vaccine, measles and rubella combined live attenuated vaccine, Haemophilus influenzae type b combination vaccine , 23-valent pneumococcal polysaccharide vaccine, etc. Among the many products, Kangtai Biology is best known for its hepatitis B vaccine.

Has the cooling-off period passed? Some investors questioned that divorce is to reduce holdings

　　In the face of the 23.5 billion sky-high breakup fee, some netizens couldn't help but ask: "Doesn't you need to calm down?" "Has the cooling-off period passed?" However, stockholders are more concerned about: "How to allocate voting rights?"

　　The announcement of Kangtai Biology shows that in order to maintain the normal operation of Kangtai Biology and continue to maintain Du Weimin's actual control of Kangtai Biology, Du Weimin and Yuan Liping signed the "Entrustment Agreement for Actors and Voting Rights". The agreement stipulates: Yuan Liping agreed to delegate the shareholder rights of the shares he held to Du Weimin, and the two established a concerted action relationship.

Du Weimin, chairman of Kangtai Biology. Screenshot from Kangtai Bio WeChat public account

　　In other words, Yuan Liping will still take concerted action with Du Weimin when voting at the shareholders' meeting of the listed company and the board of directors, and maintain the consistency of the voting results.

　　Since the current stock price of Kangtai Biotech is at a historically high level, some netizens questioned whether it would be a "divorce reduction?" "Another way to cut leek?" "If it is a fake divorce, then it is our small casualties." They must reduce their holdings. If it is a real divorce, they will not necessarily reduce holdings. "

　　Regarding Du Weimin and Yuan Liping ’s future shareholding plans, Kangtai Bio ’s “Simple Change of Equity Report” shows that the information disclosure obligor does not rule out the possibility of increasing or decreasing its shares in the listed company within the next 12 months.

　　"Look at the stock price performance on Monday." Some investors said.

Those sky-high “breakup fees” for A shares

　　The sky-high break-up fee for A shares not only affects the hearts of investors, but also brings talks to the “people who eat melons”. After all, A shares have no shortage of sky-high breakup fees.

　　In addition to the record breaking fee of 23.5 billion yuan, and the record of the break-up fee of 7.5 billion yuan by Zhou Yahui, chairman of Kunlun Wanwei in September 2016, there are also hundreds of millions of yuan of break-up fees for many listed company bosses or executives. Case.

Data map: RMB. Jin Shuoshe

　　In October 2013, Wang Ning, chairman of Shenzhou Taiyue, split his 120 million shares under the name of his ex-wife An Mei due to divorce. The equity value was as high as 1.23 billion yuan.

　　On January 28, 2016, the Academy of Electric Power announced that Hu Cu, the real controller, planned to transfer 32 million shares (4.44% of the total share capital) to Wang Ping for free, on the grounds that the divorce property was split. yuan.

　　On January 4, 2017, Yixintang announced that the controlling shareholder Ruan Hongxian and Liu Qiong had gone through the divorce procedures. After the shares were split, the two held a stock market value of 3.7 billion yuan and 2 billion yuan, respectively.

　　In January 2017, Mengjie Chairman Jiang Tianwu and his wife Wu Jing signed the "Divorce Agreement", splitting 127 million shares into Wu Jing's name, with a market value of about 1 billion yuan.

　　In December 2018, the baby room shareholder Zheng Dali split 3.9 million shares to Yang Qingfen due to marital relationship, accounting for 3.9% of the company's total share capital. According to the latest price on that day, the market value is close to 168 million yuan.

　　In September 2019, Zhou Heping, the largest shareholder of Wall Nuclear Materials, transferred the 182 million shares he held to his ex-wife on the divorce property division. Based on the market value at the time, it was equivalent to a "breakup fee" of about 900 million yuan.

　　In January 2020, Shen Xiaoyu, the actual controller of Tony Electronics' post-80s, transferred his 12.0915 million shares to the name of his ex-wife and paid a "breakup fee" worth more than 300 million yuan.

　　In February 2020, Xu Jiadong, a 15.22% shareholder of Cross-Border Communications, and Li Junqiu handled the dissolution of marriage relationship. Xu Jiadong split 70.11 million shares (accounting for 4.50% of the company's total shares) into Li Junqiu. At that time, the market value was 460 million yuan.

　　"High! It's really high!" The sky-high "breakup fee" of A shares made many people unable to help feeling, "It's true that the price of love is higher." (End)